Malik, D., Tarek, M., Caceres del Carpio, J., Ramirez, C., Boyer, D., Kenney, M. C., & Kuppermann, B. D. (2014). Safety profiles of anti-VEGF drugs: Bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture. BMJ Publishing Group.

Malik, Deepika, Mohamed Tarek, Javier Caceres del Carpio, Claudio Ramirez, David Boyer, M Cristina Kenney, and Baruch D. Kuppermann. Safety Profiles of Anti-VEGF Drugs: Bevacizumab, Ranibizumab, Aflibercept and Ziv-aflibercept On Human Retinal Pigment Epithelium Cells in Culture. BMJ Publishing Group, 2014.

Malik, Deepika, et al. Safety Profiles of Anti-VEGF Drugs: Bevacizumab, Ranibizumab, Aflibercept and Ziv-aflibercept On Human Retinal Pigment Epithelium Cells in Culture. BMJ Publishing Group, 2014.